Health and wellness products company USANA Health Sciences (NYSE:USNA) will be announcing earnings results tomorrow afternoon. Here’s what investors should know.
USANA missed analysts’ revenue expectations by 2.7% last quarter, reporting revenues of $200.2 million, down 6.2% year on year. It was a slower quarter for the company, with full-year revenue guidance slightly missing analysts’ expectations.
Is USANA a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting USANA’s revenue to decline 5.5% year on year to $208.8 million, a further deceleration from the 3% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.49 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. USANA has missed Wall Street’s revenue estimates three times over the last two years.
Looking at USANA’s peers in the personal care segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Herbalife posted flat year-on-year revenue, beating analysts’ expectations by 0.6%, and Medifast reported a revenue decline of 37.7%, topping estimates by 4.2%. Herbalife traded up 42.5% following the results while Medifast was down 11.5%.
Read our full analysis of Herbalife’s results here and Medifast’s results here.
Inflation has progressed towards the Fed’s 2% goal as of late, leading to strong stock market performance. Recent rate cuts and the 2024 Presidential election's conclusion added further sparks to the market, and while some of the personal care stocks have shown solid performance, the group has generally underpeformed, with share prices down 2.5% on average over the last month. USANA is down 8% during the same time and is heading into earnings with an average analyst price target of $51.50 (compared to the current share price of $31.62).
Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
